LEAP2 and Cognitive impairment: The elevated LEAP2/ghrelin molar ratio accompanying aging blunted hippocampal ghrelin signaling, resulting in suppressed hippocampal synaptic function, impaired hippocampal neurogenesis, and neuroinflammatory damage, culminating in cognitive deficits.